IL53441A0 - Methyladamantyl hydrazines their preparation and pharmaceutical compositions containing them - Google Patents
Methyladamantyl hydrazines their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL53441A0 IL53441A0 IL53441A IL5344177A IL53441A0 IL 53441 A0 IL53441 A0 IL 53441A0 IL 53441 A IL53441 A IL 53441A IL 5344177 A IL5344177 A IL 5344177A IL 53441 A0 IL53441 A0 IL 53441A0
- Authority
- IL
- Israel
- Prior art keywords
- methyladamantyl
- hydrazines
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/28—Nitrogen atoms
- C07D295/30—Nitrogen atoms non-acylated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL53441A IL53441A0 (en) | 1977-11-22 | 1977-11-22 | Methyladamantyl hydrazines their preparation and pharmaceutical compositions containing them |
CA000315362A CA1120471A (fr) | 1977-11-22 | 1978-10-31 | Obtention de 2-adamantylhydrazines et de substances pharmaceutiques qui en contiennent |
EP78101411A EP0002065A1 (fr) | 1977-11-22 | 1978-11-20 | Méthyladamantylhydrazines, leurs sels pharmaceutiquement acceptables et compositions pharmaceutiques les contenant |
ZA00786548A ZA786548B (en) | 1977-11-22 | 1978-11-21 | Adamantylmethyl hydrazines,their preparation and pharmaceutical compositions containing them |
JP14492878A JPS5481254A (en) | 1977-11-22 | 1978-11-21 | 11or 22adamantylmethyl hydrazines or their aciddadded salt |
IT30075/78A IT1101424B (it) | 1977-11-22 | 1978-11-22 | Metiladamantil idrazine,loro preparazione e composizioni farmaceutiche che le contengono |
US05/963,114 US4202892A (en) | 1977-11-22 | 1978-11-22 | Biocidal methyladamantyl hydrazines and pharmaceutical compositions containing them |
AU41842/78A AU4184278A (en) | 1977-11-22 | 1978-11-22 | Adamantylmethyl hydrazines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL53441A IL53441A0 (en) | 1977-11-22 | 1977-11-22 | Methyladamantyl hydrazines their preparation and pharmaceutical compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
IL53441A0 true IL53441A0 (en) | 1978-01-31 |
Family
ID=11049918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL53441A IL53441A0 (en) | 1977-11-22 | 1977-11-22 | Methyladamantyl hydrazines their preparation and pharmaceutical compositions containing them |
Country Status (8)
Country | Link |
---|---|
US (1) | US4202892A (fr) |
EP (1) | EP0002065A1 (fr) |
JP (1) | JPS5481254A (fr) |
AU (1) | AU4184278A (fr) |
CA (1) | CA1120471A (fr) |
IL (1) | IL53441A0 (fr) |
IT (1) | IT1101424B (fr) |
ZA (1) | ZA786548B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4691051A (en) * | 1985-01-04 | 1987-09-01 | Pennwalt Corporation | Adamantyl phenyl β-alanines |
US5506231A (en) * | 1989-03-31 | 1996-04-09 | The Children's Medical Center Corporation | Treatment of aids dementia, myelopathy and blindness |
US5334618A (en) * | 1991-04-04 | 1994-08-02 | The Children's Medical Center Corporation | Method of preventing NMDA receptor-mediated neuronal damage |
US5614560A (en) * | 1991-04-04 | 1997-03-25 | Children's Medical Center Corporation | Method of preventing NMDA receptor-mediated neuronal damage |
US5488035A (en) * | 1991-12-06 | 1996-01-30 | Pioneer Hi-Bred International, Inc. | Peptide with inhibitory activity towards plant pathogenic fungi |
US5977360A (en) | 1996-12-27 | 1999-11-02 | Japan Hydrazine Co., Ltd. | Process for producing cyclic hydrazine derivatives, tetra-hydropyridazine and hexahydropyridazine |
GB0013737D0 (en) | 2000-06-07 | 2000-07-26 | Astrazeneca Ab | Novel compounds |
SE0103836D0 (sv) * | 2001-11-16 | 2001-11-16 | Astrazeneca Ab | Novel compounds |
SE0300480D0 (sv) | 2003-02-21 | 2003-02-21 | Astrazeneca Ab | Novel compounds |
GB0312609D0 (en) | 2003-06-02 | 2003-07-09 | Astrazeneca Ab | Novel compounds |
WO2005120186A2 (fr) * | 2003-07-01 | 2005-12-22 | The University Of Akron | Methyle 2,4,9-trithiaadamantane-7-carboxylate |
WO2005003089A2 (fr) * | 2003-07-01 | 2005-01-13 | The University Of Akron | 7-ethynyl-2,4,9-trithiaadamantane et procedes afferents |
ES2388454T3 (es) | 2007-03-22 | 2012-10-15 | Astrazeneca Ab | Derivados de quinolina para el tratamiento de enfermedades inflamatorias |
PE20091036A1 (es) | 2007-11-30 | 2009-08-15 | Astrazeneca Ab | Derivado de quinolina como antagonista del receptor p2x7 |
US8066914B2 (en) * | 2008-03-17 | 2011-11-29 | University Of Akron | 7-ethynyl-2,4,9-trithiaadamantane and related methods |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1105410B (de) * | 1959-09-30 | 1961-04-27 | Bayer Ag | Verfahren zur Herstellung von stimulierend wirksamen Hydrazinderivaten |
US3719710A (en) * | 1968-09-20 | 1973-03-06 | Pennwalt Corp | Preparation of hydrazinoadamantane compounds |
US4061774A (en) * | 1974-03-02 | 1977-12-06 | Lilly Industries, Limited | Halogenated amino methyl adamantane derivatives |
-
1977
- 1977-11-22 IL IL53441A patent/IL53441A0/xx not_active IP Right Cessation
-
1978
- 1978-10-31 CA CA000315362A patent/CA1120471A/fr not_active Expired
- 1978-11-20 EP EP78101411A patent/EP0002065A1/fr not_active Withdrawn
- 1978-11-21 JP JP14492878A patent/JPS5481254A/ja active Pending
- 1978-11-21 ZA ZA00786548A patent/ZA786548B/xx unknown
- 1978-11-22 AU AU41842/78A patent/AU4184278A/en active Pending
- 1978-11-22 IT IT30075/78A patent/IT1101424B/it active
- 1978-11-22 US US05/963,114 patent/US4202892A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IT1101424B (it) | 1985-09-28 |
US4202892A (en) | 1980-05-13 |
IT7830075A0 (it) | 1978-11-22 |
EP0002065A1 (fr) | 1979-05-30 |
JPS5481254A (en) | 1979-06-28 |
AU4184278A (en) | 1979-05-31 |
CA1120471A (fr) | 1982-03-23 |
ZA786548B (en) | 1979-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL51660A0 (en) | Hentriakontapeptides their preparation and pharmaceutical compositions containing them | |
IL51816A0 (en) | Novel steroids their preparation and pharmaceutical compositions containing them | |
IL56992A0 (en) | N-heterocyclyl-4-piperidinamines their preparation and pharmaceutical compositions containing them | |
IL53043A0 (en) | Novel 1-aryloxy-2-hydroxy-3-aminopropane - derivatives their preparation and pharmaceutical compositions containing them | |
MY8700186A (en) | 3-aminopropoxyaryl derivatives their preparation and pharmaceutical compositions containing them | |
IL53589A0 (en) | Novel nucleosides their preparation and pharmaceutical compositions containing them | |
IL54519A0 (en) | 2-diarylalkyl-1-azabicyclo (2,2,2) octanes, their preparation and pharmaceutical compositions containing them | |
IL53441A0 (en) | Methyladamantyl hydrazines their preparation and pharmaceutical compositions containing them | |
IL50631A (en) | 1-benzazolylalkyl-4-substituted-piperidines their preparation and pharmaceutical compositions containing them | |
DE2862107D1 (en) | Glucosamine-peptide derivatives and their pharmaceutical compositions | |
GB1544191A (en) | Acylaminopiperidines processes for their preparation and pharmaceutical compositions containing them | |
GB2002779B (en) | Peptides their preparation and pharmaceutical compositions containing them | |
IL52137A0 (en) | Novel aryltrifluoroethylamines their preparation and pharmaceutical compositions containing them | |
IL60376A0 (en) | 3-methyleneazetidine derivatives and pharmaceutical compositions containing them | |
IL54358A (en) | 1-substituted-3-amino-6,7-dialkoxy-1h-1,2,4-benzothiadiazine-1-oxides,their preparation and pharmaceutical compositions containing them | |
GB2001653B (en) | Peptides their preparation and pharmaceutical compositions containing them | |
IL58620A0 (en) | Aryltrifluoroethanol derivatives their preparation and pharmaceutical compositions containing them | |
IL54073A0 (en) | Solid pharmaceutical compositions containing steroids and their preparation | |
IL59177A0 (en) | Spiro-quinolylhydantoins and pharmaceutical compositions containing them | |
IL53440A0 (en) | 2-adamantyl hydrazines their preparation and pharmaceutical compositions containing them | |
GB2010261B (en) | Phenoxyalkanolamine derivatives the preparation thereof and pharmaceutical compositions containing them | |
IL51468A0 (en) | Novel d-homosteroids their preparation and pharmaceutical compositions containing them | |
IL53026A0 (en) | New pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them | |
IL52006A0 (en) | Novel nephthalene derivatives their preparation and pharmaceutical compositions containing them | |
IL60695A0 (en) | Hexahydro-trans-pyridoindole derivatives and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH | Patent void |